R1 RCM Inc. Nasdaq

Equities

RCM

US7493971052

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
13 USD 0.00% Intraday chart for R1 RCM Inc. -1.14% -44.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Investors -2- DJ
News Highlights : Top Financial Services News of the Day - Thursday at 12 AM ET DJ
News Highlights : Top Financial Services News of the Day - Wednesday at 4 PM ET DJ
Canaccord Genuity Trims Price Target on R1 RCM to $16 From $17, Maintains Buy Rating MT
Citigroup Upgrades R1 RCM to Buy From Neutral, Price Target is $16 MT
R1 RCM Calls for Halt to Talks About Potential Deal MT
Transcript : R1 RCM Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 04:35 PM
R1 RCM Forms Special Committee to Evaluate Strategic Alternatives MT
North American Morning Briefing : Stock Futures -2- DJ
Truist Securities Downgrades R1 RCM to Hold From Buy, Price Target is $16 MT
Transcript : R1 RCM Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 10:30 AM
KeyBanc Raises Price Target on R1 RCM to $17 From $13, Maintains Overweight Rating MT
North American Morning Briefing : Fed's Preferred -2- DJ
Barclays Downgrades R1 RCM to Equalweight From Overweight, Price Target is $14 MT
Evercore ISI Downgrades R1 RCM to In Line From Outperform, Raises Price Target to $16 From $12 MT
Deutsche Bank Downgrades R1 RCM to Hold From Buy, $15 Price Target MT
Sector Update: Health Care Stocks Mixed Premarket Tuesday MT
R1 RCM Reports Breakeven Q4 Earnings; Revenue Rises; 2024 Outlook Issued, Shares Advance Pre-Bell MT
Transcript : R1 RCM Inc., Q4 2023 Earnings Call, Feb 27, 2024
R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
R1 RCM Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
R1 RCM Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North American Morning Briefing : Stock Futures -2- DJ
R1 RCM majority shareholders consider taking company private RE
Sector Update: Health Care Stocks Ease Late Afternoon MT
Chart R1 RCM Inc.
More charts
R1 RCM Inc. is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. The Company assists healthcare providers in generating sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for its customers. The Company’s hospitals and health systems solutions include end-to-end revenue cycle management, patient experience, physician advisory, and coding management. The Company’s physician group’s solutions include revenue cycle management solutions, and practice management solutions. The Company’s R1 Entri is intelligent patient experience solution that ensures patient and provider interactions start strong and develop into lasting relationships. The Company’s intelligent automation (IA) ecosystem modernizes processes, removes friction and simplifies revenue cycle management (RCM).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
13 USD
Average target price
17.14 USD
Spread / Average Target
+31.87%
Consensus
  1. Stock
  2. Equities
  3. Stock R1 RCM Inc.
  4. Stock R1 RCM Inc. - Nasdaq
  5. News R1 RCM Inc.
  6. R1 RCM To Provide Revenue Cycle Management Services for 10 Years to ScionHealth